Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Evaluation of the Pathobiology of CALR-mutated MPN Cells — Stella

Home/Myeloproliferative Neoplasm/Evaluation of the Pathobiology of CALR-mutated MPN Cells

View on ClinicalTrials.gov

Recruiting

Back to Myeloproliferative Neoplasm trials

Evaluation of the Pathobiology of CALR-mutated MPN Cells

Trial locations(2 sites)

United States

Atrium Health Levine Cancer, Charlotte, North Carolina

Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina

Key details

Sponsor

Wake Forest University Health Sciences

Collaborators

Atrium Health Levine Cancer Institute, Brookdale University Hospital Medical Center

Enrollment target

~35 participants

Started

January 2025

Primary completion

July 2026

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.